Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · IEX Real-Time Price · USD
4.160
+0.050 (1.22%)
At close: Jul 19, 2024, 12:00 AM
4.220
+0.060 (1.44%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Xenetic Biosciences Employees
Xenetic Biosciences had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$611,240
Profits / Employee
-$1,118,284
Market Cap
6.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CareMax | 1,450 |
| Telesis Bio | 147 |
| Sunshine Biopharma | 44 |
| ReShape Lifesciences | 29 |
| Pasithea Therapeutics | 8 |
| Tenax Therapeutics | 6 |
| Alaunos Therapeutics | 1 |
XBIO News
- 2 months ago - Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update - Accesswire
- 4 months ago - Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results - Accesswire
- 6 months ago - Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform - Accesswire
- 9 months ago - Xenetic Biosciences, Inc. Reports Third Quarter 2023 Financial Results - Accesswire
- 10 months ago - Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference - Accesswire
- 11 months ago - Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference - Accesswire
- 1 year ago - Xenetic Biosciences, Inc. Reports Second Quarter 2023 Financial Results - Accesswire
- 1 year ago - Xenetic Biosciences, Inc. to Participate in the Virtual Investor Summer Spotlight Series - Accesswire